Evidence
J Perinatol. 2024 Jan 24. doi: 10.1038/s41372-024-01882-x. Online ahead of print.
ABSTRACT
OBJECTIVE: To estimate trends in maternal opioid use disorder (OUD) and neonatal abstinence syndrome (NAS) in Maine using the most recent data available.
STUDY DESIGN: We used hospital discharge data to estimate the annual prevalence of maternal OUD and NAS between 2016 and 2022. In addition, we used birth certificate-linked Medicaid data to estimate related trends among Medicaid enrollees.
RESULT: From 2016 to 2022, the prevalence of maternal OUD decreased from 35.3 to 18.8 per 1000 deliveries and the prevalence of NAS decreased from 33.2 to 14.0 per 1000 newborns (linear trend p values <0.01). Decreasing trends were also found among Medicaid enrollees.
CONCLUSION: In Maine between 2016 and 2022, there was a decrease in maternal OUD and NAS diagnoses recorded in administrative datasets. These findings should be interpreted with caution due to changes in how OUD and NAS diagnoses are recorded and COVID-related changes in healthcare utilization.
PMID:38267636 | DOI:10.1038/s41372-024-01882-x
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
🌐 90 Days
VR Related Evidence Matrix
- Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing
- Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
- Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity
- Application of an opioid use disorder cascade of care in a large public health system
- Prenatal cannabis use disorder and gastroschisis in California, 2007-19
- Diagnosis of Perinatal Mental Health Conditions Following Medicaid Expansion to Include Low-Income Immigrants
- Genome-wide association study reveals multiple loci for analgesia and opioid consumption behaviors associated with heroin vulnerability in outbred rats
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
- Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment
- Maternal pre-pregnancy and prenatal penicillin, neonatal inflammation and growth factors are associated to ADHD in the offspring
- The impact of excessive maternal weight on the risk of neuropsychiatric disorders in offspring-a narrative review of clinical studies
- Risk of Adverse Neonatal Outcomes After Combined Prenatal Cannabis and Nicotine Exposure
- Risk of Adverse Neonatal Outcomes After Combined Prenatal Cannabis and Nicotine Exposure
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
- Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
- Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022
- 'Joining the Dots: Linking Prenatal Drug Exposure to Childhood and Adolescence' - research protocol of a population cohort study
- Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians
- National trends in counseling for stress and depression and COVID-19 pandemic-related factors among adults, 2009-2022: A nationwide study in South Korea: Stress, depression, and pandemic
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Binge drinking in early adolescence : Results of the "Präventionsradar" from 2016 to 2023
- Nitrogen-doped magnetic porous carbon nanospheres derived from dual templates-induced mesoporous polydopamine coated Fe3O4 for efficient extraction and sensitive determination of volatile nitrosamines by gas chromatography-mass spectroscopy
- Levels of engagement among office-based opioid treatment (OBOT) patients with concurrent methamphetamine use
- Maternal asthma and asthma exacerbation during pregnancy and attention-deficit/hyperactivity disorder in offspring: a population-based cohort study
- Maternal prenatal social disadvantage and neonatal functional connectivity: Associations with psychopathology symptoms at age 12 months
- Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
- Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019
- Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors
- Investigating the Black Birth Experience: A Race-Stratified Analysis of Preterm Birth Risk and Exposure to Metropolitan Statistical Area-Level Police-Related Deaths, US 2018-2019
- The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study of women and providers
- Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany
- Fluctuations in Maternal Depressive Symptoms, Anxiety, and Anger and Children's Depression Risks in Middle Childhood
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study
- Maternal Childhood Adversity and Infant Epigenetic Aging: Moderation by Restless Sleep During Pregnancy
- Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic
- Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study
- Prevalence of Opioid Use Disorder and Opioid Overdose Rates Among People With Mental Illness
- Do maternal anxiety and depressive symptoms predict anxiety in children with and without ADHD at 8 years?
- Birth in Brazil II: a postpartum maternal, paternal and child health research protocol
- Perinatal Posttraumatic Stress Disorder Diagnoses Among Commercially Insured People Increased, 2008-20
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
- Clinical, socio-demographic, and parental correlates of early autism traits in a community cohort of toddlers
- Comparison of Opioid Use Disorder Patients with and without Problematic Internet Use in Terms of Impulsivity and Attention Deficit Hyperactivity Disorder
- Neuroembryonic and fetal brain development: Relevance to fetal/neonatal neurological training
- Neuroembryonic and fetal brain development: Relevance to fetal/neonatal neurological training
- Neuroembryonic and fetal brain development: Relevance to fetal/neonatal neurological training
- Examining Sex Differences in Autism Heritability
- Computational Approaches for Connecting Maternal Stress to Preterm Birth
- The prevalence of rumination syndrome and rumination disorder: A systematic review and meta-analysis
- Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
- Burden of depression in adolescents in the Western Pacific Region from 1990 to 2019: An age-period-cohort analysis of the Global Burden of Disease study
- Burden of depression in adolescents in the Western Pacific Region from 1990 to 2019: An age-period-cohort analysis of the Global Burden of Disease study
- The unique role of adolescent internalizing and externalizing problems, and maternal-adolescent communication in their association with attachment in early adulthood
- Opioid use and risks in liver transplant candidates and recipients
Evidence Blueprint
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022
🌐 365 Days
VR Related Evidence Matrix
- Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
- Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review
- National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018
- Trends, Characteristics, and Maternal Morbidity Associated With Unhoused Status in Pregnancy
- Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA
- Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic
- Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing
- Parent and grandparent neonatal intensive care unit visitation for preterm infants
- The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose
- Differing time trends for alcohol misuse and alcohol use disorder among Veteran men: A comparison of population surveillance and clinical data
- Neonatal autonomic regulation as a predictor of autism symptoms in very preterm infants
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Neighborhood Income Mobility and Risk of Neonatal and Maternal Morbidity
- Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012
- Timing of treatment for opioid use disorder among birthing people
- Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010-2019
- Effect of parental adverse childhood experiences on intergenerational DNA methylation signatures from peripheral blood mononuclear cells and buccal mucosa
- High-deductible Health Plans and Nonfatal Opioid Overdose
- Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
- Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?
- Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities
- Neuroimmune mechanisms of opioid use disorder and recovery: Translatability to human studies, and future research directions
- Psychotherapies in opioid use disorder: toward a step-care model
- Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers
- Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
- An Appraisal of Using Opioids in Patients with Opioid Use Disorder
- Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder
- Common mental disorders and perinatal outcomes in Victoria, Australia: A population-based retrospective cohort study
- State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
- Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
- Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
- Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity
- Application of an opioid use disorder cascade of care in a large public health system
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Prenatal cannabis use disorder and gastroschisis in California, 2007-19
- Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study
- Temporal changes in pre-existing health conditions five years prior to pregnancy in British Columbia, Canada, 2000-2019
- Diagnosis of Perinatal Mental Health Conditions Following Medicaid Expansion to Include Low-Income Immigrants
- First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
- Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs
- Identification of opioid use disorder using electronic health records: Beyond diagnostic codes
- Genome-wide association study reveals multiple loci for analgesia and opioid consumption behaviors associated with heroin vulnerability in outbred rats
- Extended-release Buprenorphine Administered at Discharge in Hospitalized Persons With Opioid Use Disorder: A Case Series
- Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder
- Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients
- Levels and trends in mortality and causes of death among women of reproductive age in Bangladesh: Findings from three national surveys
- Transcriptional signatures of heroin intake and relapse throughout the brain reward circuitry in male mice
- Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder
- Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
- Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021
- Pregnancy characteristics and outcomes among birthing individuals with a diagnosis of fetal alcohol syndrome
- Buprenorphine and Opioid Use Disorder Training: Graduate Nursing Curricula Recommendations
- The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants
- Emergency Department Access to Buprenorphine for Opioid Use Disorder
- Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus
- Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
- Framing Chronic Pain in U.S. News Coverage of the Opioid Epidemic (2012-2022)
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment